Published 5 hours ago • loading... • Updated 59 minutes ago

Misinformation, hesitancy could blunt impact of new cancer vaccines

Cary, North Carolina — A new generation of cancer vaccines is showing encouraging results in clinical trials, but researchers worry growing vaccine hesitancy could limit their impact if the treatments eventually reach patients. One example comes from the Cleveland Clinic, where an experimental vaccine targeting triple-negative breast cancer produced an immune response in 74% of 35 participants in a Phase 1 trial. Researchers stressed that the st…

9 Articles

Pennsylvania Capital-Star

+8 Reposted by 8 other sources

Lean Left

Misinformation, hesitancy could blunt impact of new cancer vaccines

Just last month, pharmaceutical companies Moderna and Merck announced that a personalized mRNA cancer vaccine, combined with an immunotherapy drug, had succeeded in a late-stage trial for skin cancer. The news raised hopes that a wave of new cancer vaccines could be just over the horizon.

4 hours ago

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year